Key Highlights
- Lynx closes an oversubscribed $27 million Series A round, bringing total funding to $44 million since its 2022 launch.
- Flare Capital Partners leads the round, with participation from CVS Health Ventures, McKesson Ventures, .406 Ventures, Obvious Ventures, and Frist Cressey Ventures.
- Funding will drive growth in:
- Medicare Advantage supplemental benefits, Medicaid value-added benefits, and ICHRA innovation
- Consumer-Directed Health (CDH) account administration and compliance enhancements
- API-driven product development to streamline healthcare payments
- Victor Lanio, Partner at Flare Capital, joins Lynx’s board.
Source: Direct
Notable Quotes
“In a fragmented healthcare payments landscape, Lynx is the only platform that supports all healthcare payment types and use cases. This oversubscribed round is a testament to Lynx’s exceptional traction, visionary leadership, and the growing demand for a truly unified solution.” — Victor Lanio, Partner at Flare Capital Partners
“This recent funding will fuel our expansion across all channels, empowering us to continue driving innovation and delivering exceptional value to health plans, financial institutions, administrators, and members alike.” — Matthew Renfro, Co-Founder & CEO at Lynx
Why This Matters
The healthcare payments sector is highly fragmented, making transactions inefficient and cumbersome for providers, payers, and consumers alike. Lynx’s API-driven platform unifies healthcare payments across multiple markets, including Medicare Advantage, Medicaid, and ICHRA. With this funding, Lynx is poised to accelerate innovation and scalability, making healthcare financial transactions more seamless and efficient for all stakeholders.
